BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

300 related articles for article (PubMed ID: 26950279)

  • 1. Escitalopram attenuates β-amyloid-induced tau hyperphosphorylation in primary hippocampal neurons through the 5-HT1A receptor mediated Akt/GSK-3β pathway.
    Wang YJ; Ren QG; Gong WG; Wu D; Tang X; Li XL; Wu FF; Bai F; Xu L; Zhang ZJ
    Oncotarget; 2016 Mar; 7(12):13328-39. PubMed ID: 26950279
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Escitalopram Ameliorates Forskolin-Induced Tau Hyperphosphorylation in HEK239/tau441 Cells.
    Ren QG; Wang YJ; Gong WG; Zhou QD; Xu L; Zhang ZJ
    J Mol Neurosci; 2015 Jun; 56(2):500-8. PubMed ID: 25687330
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of glycogen synthase kinase-3β by Angelica sinensis extract decreases β-amyloid-induced neurotoxicity and tau phosphorylation in cultured cortical neurons.
    Zhang Z; Zhao R; Qi J; Wen S; Tang Y; Wang D
    J Neurosci Res; 2011 Mar; 89(3):437-47. PubMed ID: 21259330
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Escitalopram Ameliorates Tau Hyperphosphorylation and Spatial Memory Deficits Induced by Protein Kinase A Activation in Sprague Dawley Rats.
    Ren QG; Wang YJ; Gong WG; Xu L; Zhang ZJ
    J Alzheimers Dis; 2015; 47(1):61-71. PubMed ID: 26402755
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Naringin Protects against Tau Hyperphosphorylation in A
    Qiu Q; Lei X; Wang Y; Xiong H; Xu Y; Sun H; Xu H; Zhang N
    Behav Neurol; 2023; 2023():1857330. PubMed ID: 36844418
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Isorhynchophylline treatment improves the amyloid-β-induced cognitive impairment in rats via inhibition of neuronal apoptosis and tau protein hyperphosphorylation.
    Xian YF; Mao QQ; Wu JC; Su ZR; Chen JN; Lai XP; Ip SP; Lin ZX
    J Alzheimers Dis; 2014; 39(2):331-46. PubMed ID: 24164737
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dendrobium nobile Lindl. alkaloid decreases Tau hyperphosphorylation via regulating PI3K/Akt/GSK-3β pathway in vitro and in vivo.
    Huang J; Huang N; Qiu Y; Shi J
    J Ethnopharmacol; 2024 Mar; 322():117592. PubMed ID: 38097026
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Allantoin ameliorates amyloid β-peptide-induced memory impairment by regulating the PI3K/Akt/GSK-3β signaling pathway in rats.
    Tzeng CY; Lee WS; Liu KF; Tsou HK; Chen CJ; Peng WH; Tsai JC
    Biomed Pharmacother; 2022 Sep; 153():113389. PubMed ID: 36076477
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 17beta-estradiol attenuates glycogen synthase kinase-3beta activation and tau hyperphosphorylation in Akt-independent manner.
    Shi HR; Zhu LQ; Wang SH; Liu XA; Tian Q; Zhang Q; Wang Q; Wang JZ
    J Neural Transm (Vienna); 2008 Jun; 115(6):879-88. PubMed ID: 18217188
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Subcutaneous administration of liraglutide ameliorates learning and memory impairment by modulating tau hyperphosphorylation via the glycogen synthase kinase-3β pathway in an amyloid β protein induced alzheimer disease mouse model.
    Qi L; Ke L; Liu X; Liao L; Ke S; Liu X; Wang Y; Lin X; Zhou Y; Wu L; Chen Z; Liu L
    Eur J Pharmacol; 2016 Jul; 783():23-32. PubMed ID: 27131827
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Stimulation of EphB2 attenuates tau phosphorylation through PI3K/Akt-mediated inactivation of glycogen synthase kinase-3β.
    Jiang J; Wang ZH; Qu M; Gao D; Liu XP; Zhu LQ; Wang JZ
    Sci Rep; 2015 Jun; 5():11765. PubMed ID: 26119563
    [TBL] [Abstract][Full Text] [Related]  

  • 12. TREM2 Inhibits Tau Hyperphosphorylation and Neuronal Apoptosis via the PI3K/Akt/GSK-3β Signaling Pathway In vivo and In vitro.
    Peng X; Guo H; Zhang X; Yang Z; Ruganzu JB; Yang Z; Wu X; Bi W; Ji S; Yang W
    Mol Neurobiol; 2023 May; 60(5):2470-2485. PubMed ID: 36662361
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Melatonin ameliorates amyloid beta-induced memory deficits, tau hyperphosphorylation and neurodegeneration via PI3/Akt/GSk3β pathway in the mouse hippocampus.
    Ali T; Kim MO
    J Pineal Res; 2015 Aug; 59(1):47-59. PubMed ID: 25858697
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gypenoside IX restores Akt/GSK-3β pathway and alleviates Alzheimer's disease-like neuropathology and cognitive deficits.
    Lei L; Luo Y; Kang D; Yang F; Meng D; Wang JZ; Liu R; Wang X; Li HL
    Aging (Albany NY); 2023 Dec; 15(23):14172-14191. PubMed ID: 38095632
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The protective underlying mechanisms of Schisandrin on SH-SY5Y cell model of Alzheimer's disease.
    Zhao ZY; Zhang YQ; Zhang YH; Wei XZ; Wang H; Zhang M; Yang ZJ; Zhang CH
    J Toxicol Environ Health A; 2019; 82(19):1019-1026. PubMed ID: 31739764
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Glucagon-like peptide-1 protects hippocampal neurons against advanced glycation end product-induced tau hyperphosphorylation.
    Chen S; An FM; Yin L; Liu AR; Yin DK; Yao WB; Gao XD
    Neuroscience; 2014 Jan; 256():137-46. PubMed ID: 24183963
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hyperforin attenuates aluminum-induced Aβ production and Tau phosphorylation via regulating Akt/GSK-3β signaling pathway in PC12 cells.
    Huang W; Cheng P; Yu K; Han Y; Song M; Li Y
    Biomed Pharmacother; 2017 Dec; 96():1-6. PubMed ID: 28961505
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Implication of phosphatidylinositol-3 kinase/Akt/glycogen synthase kinase-3β pathway in ginsenoside Rb1's attenuation of beta-amyloid-induced neurotoxicity and tau phosphorylation.
    Zhao R; Zhang Z; Song Y; Wang D; Qi J; Wen S
    J Ethnopharmacol; 2011 Feb; 133(3):1109-16. PubMed ID: 21129477
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Curcumin attenuates amyloid-β-induced tau hyperphosphorylation in human neuroblastoma SH-SY5Y cells involving PTEN/Akt/GSK-3β signaling pathway.
    Huang HC; Tang D; Xu K; Jiang ZF
    J Recept Signal Transduct Res; 2014 Feb; 34(1):26-37. PubMed ID: 24188406
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Escitalopram alleviates stress-induced Alzheimer's disease-like tau pathologies and cognitive deficits by reducing hypothalamic-pituitary-adrenal axis reactivity and insulin/GSK-3β signal pathway activity.
    Wu C; Gong WG; Wang YJ; Sun JJ; Zhou H; Zhang ZJ; Ren QG
    Neurobiol Aging; 2018 Jul; 67():137-147. PubMed ID: 29656013
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.